Pizzuti Dana bought CRNX
March 20, 2024 · Form 4 insider transaction
Pizzuti Dana bought 10,000 shares of Crinetics Pharmaceuticals Inc at $16.89 per share, a transaction worth $168.9K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
10,000
Price
$16.89
Total value
$168.9K
InsiderPizzuti Dana
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateMarch 20, 2024
Filing dateMarch 22, 2024
Shares owned after38,500
OwnershipDirect
10b5-1 planNo
AmendedNo